Wk 5 Anti-Anginal Medications Review

Overview of Angina Pectoris and Myocardial Infarction

  • Unstable Angina:

    • Defined as chest pain that occurs at any point in time, even during rest or sleep.

    • Represents a significant compromise in blood flow to the heart muscle compared to stable angina.

    • Requires more aggressive management than simple pain control due to the high risk of progressing to an infarction.

  • Prinzmetal Angina (Variant Angina):

    • Typically occurs for a short duration, often in the middle of the night or early morning.

    • Caused by vasospasm of the coronary arteries rather than physical narrowing (atherosclerosis).

    • Sudden onset that resolves once the spasm is relieved.

  • Myocardial Infarction (MI):

    • A medical emergency involving death or damage to the heart muscle due to lack of oxygen.

    • Failure to treat MI quickly can result in death, heart failure, or cardiomyopathy.

    • Clinical Manifestations:

      • Chest pain and arm pain (may radiate down the arm).

      • Diaphoresis (profuse sweating).

      • Changes in EKG readings.

      • Drop in O2O_2 saturation levels.

      • Blood pressure fluctuations (can be severely hypertensive or hypotensive).

    • Cardiac Markers:

      • Troponin: A key cardiac marker elevation indicating injury to the heart muscle.

      • High Sensitivity Troponin: A modern, more accurate standard for measuring muscle damage in hospitals.

Anti-Anginal Pharmacotherapy: Nitrates

  • Mechanism of Action:

    • Induces vasodilation of the coronary arteries and peripheral vessels.

    • Benefits: Decreases myocardial workload, decreases oxygen demand, and increases oxygen supply by allowing better perfusion to the cardiac muscle.

  • Common Medications:

    • Nitroglycerin (The prototype drug).

    • Isosorbide dinitrate.

    • Isosorbide mononitrate.

    • Amyl nitrate (an older variation, less commonly used today).

  • Routes of Administration and Onset:

    • IV Route: Onset of 11 to 22 minutes; duration of 33 to 55 minutes. If hypotension occurs, the effect wears off quickly once the infusion is stopped.

    • Sublingual / Translingual Spray: Onset of 11 to 33 minutes; duration of 3030 to 6060 minutes.

    • Transmucosal Tablet: Acts similarly to the IV route in terms of rapid effect.

    • Topical Ointment: Onset of 3030 to 6060 minutes; duration of 44 to 88 hours.

    • Transdermal Patch: Lasts for 2424 hours (though should be removed for a "drug-free" interval).

    • Oral (Sustained Release): Effective for 88 to 1212 hours.

  • Contraindications and Drug Interactions:

    • Erectile Dysfunction (ED) Medications: (e.g., Cialis, Viagra). Use of nitrates with these medications is strictly contraindicated as it can cause extreme hypotension and potential injury.

    • Severe Anemia: Vasodilation can worsen conditions where blood volume/oxygen-carrying capacity is already low.

    • Heparin: Nitrates may decrease the therapeutic effect of heparin, requiring close monitoring of coagulation risks versus benefits.

  • Adverse Effects:

    • Headache (very common due to vasodilation of cranial vessels).

    • Dizziness and Hypotension.

    • Flushing (redness of the skin due to systemic dilation).

    • Nausea and vomiting.

    • Reflex tachycardia (the heart rate increases to compensate for dropped blood pressure).

  • Patient Teaching for Nitroglycerin:

    • Acute Dosing: Take one tablet sublingually every 55 minutes for a total of 33 doses. If pain is not relieved after the third dose, the patient must call emergency services (911911).

    • Administration: Do not chew or swallow sublingual tablets.

    • Storage: Keep medication in its original dark glass bottle. It is sensitive to light. Store in a cool, dry place (avoid bathrooms due to moisture).

    • Transdermal Care: Remove old patches before applying new ones to avoid toxicity. Implement a "patch-off" period (usually 1212 hours at night) to prevent the development of nitrate tolerance.

Beta-Adrenergic Blockers (Beta Blockers)

  • Mechanism of Action:

    • Blocks the sympathetic nervous system (SNS) response.

    • Decreases heart rate and blood pressure, thereby significantly reducing the workload of the heart.

  • Common Medications:

    • Metoprolol (Prototype): Available in Oral and IV forms. IV administration results in immediate changes to blood pressure and lasts 1515 to 2020 hours.

    • Atenolol.

    • Propranolol.

    • Nadalol.

  • Contraindications and Cautions:

    • Bradycardia: Do not give if the heart rate is already too slow.

    • Cardiogenic Shock: The heart is already failing; blocking the SNS can make it worse.

    • Diabetes: Beta blockers can mask the signs of hypoglycemia (specifically tachycardia and tremors).

    • Respiratory Issues: Caution in patients with COPD or bronchospasm, as even selective beta-1 blockers can sometimes affect beta-2 receptors at higher doses.

    • Thyroid Toxicosis: Can interfere with how the body responds to a thyroid storm.

  • Drug Interactions:

    • Clonidine: Increases the risk of severe hypotension.

    • NSAIDs: These can decrease the antihypertensive effects of beta blockers due to the retention of sodium and water.

Calcium Channel Blockers

  • Clinical Use:

    • Primary choice for Prinzmetal (Variant) Angina because they effectively decrease coronary artery spasms.

    • Less effective for typical stable or unstable angina.

  • Examples:

    • Diltiazem.

    • Verapamil.

    • Nifedipine.

  • Interactions:

    • Cyclosporine: CCBs can decrease the effectiveness of cyclosporine.

    • Digoxin: CCBs can increase the risk of digoxin toxicity and cause excessive drops in heart rate.

New Drug Class: Dicaraminesetamide

  • Ranolazine (Ranexa):

    • The only drug in this specific new group.

    • Mechanism: Thought to act on the smaller vessels of the heart to promote vasodilation, though the exact mechanism remains unclear.

    • Benefits:

      • Decreases blood glucose levels in diabetic patients.

      • Decreases the incidence of ventricular dysrhythmias.

      • Helps with bradycardia in patients with chronic chest pain.

    • Dosing: Once-a-day extended-release tablet.

    • Contraindications: Severe hepatic impairment and lactation.

    • Adverse Effects: Headache, nausea, and constipation.

    • Key Interactions: Ketoconazole, macrolide antibiotics (erythromycin), diltiazem, verapamil, digoxin, and antipsychotics. These can significantly affect metabolism and lead to toxicity.

Lifespan Considerations

  • Children:

    • Nitroglycerin is commonly used but requires precise dose adjustments based on age and weight.

  • Pregnancy and Lactation:

    • Generally considered unsafe due to the risk of hypotension and fetal issues. Crosses the placenta and enters breast milk.

  • Older Adults:

    • Roughly 90%90\% of older adults may be on anti-anginal medications.

    • High risk for toxicity due to slower metabolism and excretion.

    • Requires frequent monitoring of heart rate and blood pressure before administration.

Nursing Assessment

  • Baseline Data: Obtain EKG, vital signs (HR, BP), and cardiac markers (Troponin).

  • Pain Assessment: Use the "OLD CARTS" acronym to assess location, duration, and intensity of pain.

  • Medical History: Inquire about erectile dysfunction medication use, respiratory history (COPD), pregnancy status, and history of MI.

  • Physical Exam: Assess skin (especially before CCBs or nitrate patches) and respiratory effort.